Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Use of misoprostol during pregnancy and Möbius' syndrome in infants.

Pastuszak AL, Schüler L, Speck-Martins CE, Coelho KE, Cordello SM, Vargas F, Brunoni D, Schwarz IV, Larrandaburu M, Safattle H, Meloni VF, Koren G.

N Engl J Med. 1998 Jun 25;338(26):1881-5.

2.

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study.

MacDonald TM, Morant SV, Robinson GC, Shield MJ, McGilchrist MM, Murray FE, McDevitt DG.

BMJ. 1997 Nov 22;315(7119):1333-7.

3.

Transforming growth factor beta in bovine milk: concentration, stability and molecular mass forms.

Rogers ML, Goddard C, Regester GO, Ballard FJ, Belford DA.

J Endocrinol. 1996 Oct;151(1):77-86.

PMID:
8943771
4.
5.

Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage.

Playford RJ, Marchbank T, Goodlad RA, Chinery RA, Poulsom R, Hanby AM.

Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2137-42.

6.

Safety of meloxicam: a global analysis of clinical trials.

Distel M, Mueller C, Bluhmki E, Fries J.

Br J Rheumatol. 1996 Apr;35 Suppl 1:68-77.

PMID:
8630641
7.

A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis.

Wojtulewski JA, Schattenkirchner M, Barceló P, Le Loët X, Bevis PJ, Bluhmki E, Distel M.

Br J Rheumatol. 1996 Apr;35 Suppl 1:22-8.

PMID:
8630632
8.

Human milk and intestinal host defense in newborns: an update.

Xanthou M, Bines J, Walker WA.

Adv Pediatr. 1995;42:171-208. Review.

PMID:
8540428
9.
10.

Effect of luminal growth factor preservation on intestinal growth.

Playford RJ, Woodman AC, Clark P, Watanapa P, Vesey D, Deprez PH, Williamson RC, Calam J.

Lancet. 1993 Apr 3;341(8849):843-8.

PMID:
8096559
11.

Non-steroidal anti-inflammatory drugs: how do they damage the gut?

Levi S, Shaw-Smith C.

Br J Rheumatol. 1994 Jul;33(7):605-12. Review.

PMID:
8019787
12.

Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration.

Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, Boulton RA, Thim L, Hanby AM.

Gastroenterology. 1995 Jan;108(1):108-16.

PMID:
7806031
14.

The serum-free growth of cultured cells in bovine colostrum and in milk obtained later in the lactation period.

Steimer KS, Packard R, Holden D, Klagsbrun M.

J Cell Physiol. 1981 Nov;109(2):223-34.

PMID:
7028764
16.

Human and bovine milk contain different sets of growth factors.

Shing YW, Klagsbrun M.

Endocrinology. 1984 Jul;115(1):273-82.

PMID:
6610546
17.

Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.

Langman MJ, Morgan L, Worrall A.

Br Med J (Clin Res Ed). 1985 Feb 2;290(6465):347-9.

18.

Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans.

Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, Delacey G, Gumpel MJ, Levi AJ.

Gastroenterology. 1987 Sep;93(3):480-9.

PMID:
3609658
19.

Purification and characterization of a bovine colostrum-derived growth factor.

Shing Y, Klagsbrun M.

Mol Endocrinol. 1987 May;1(5):335-8.

PMID:
3274892
20.

Supplemental Content

Support Center